Marc F Botteman (Marc Botteman)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 7

Top Topics

Prostate Cancer

Prognostic Factors

Top Venues

Journal of medical economics

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rongzhe Liu, Olalekan O Oluwole, Ibrahim Diakite, Marc F Botteman, Julia Thornton Snider, Frederick L Locke
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States. Journal of medical economics 24 (1) (2021)
Richard L Lindstrom, John P Berdahl, Eric D Donnenfeld, Vance Thompson, David Kratochvil, Chiang Wong, Heather Falvey, Grace Lytle, Marc F Botteman, John A Carter
Corneal cross-linking versus conventional management for keratoconus: a lifetime economic model. Journal of medical economics 24 (1) (2021)
Sandy Srinivas, Ateesha F Mohamed, Sreevalsa Appukkuttan, Marc F Botteman, Xinyi Ng, Namita Joshi, Jui-Hua Tsai, Jarjieh Fang, A Reginald Waldeck, Stacey J Simmons
Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment. Cancer medicine 9 (18) (2020)
Anuj Shah, Ruchit Shah, Nehemiah Kebede, Ateesha Mohamed, Marc F Botteman, Reg Waldeck, Arif Hussain
Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy. Journal of medical economics 23 (4) (2020)
Marc F Botteman, Katharina Nickel, Shelby Corman, Marco Turini, Gary Binder
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 28 (2) (2019)
Abdalla Aly, Courtney Johnson, Shuo Yang, Marc F Botteman, Sumati Rao, Arif Hussain
Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma. Journal of medical economics 22 (7) (2019)
Sang Hee Park, Gary Binder, Shelby Corman, Marc F Botteman
Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomiting. Journal of medical economics 22 (8) (2019)